ANP-GNP

This 10 hour comprehensive Pharmacology and Infectious Diseases Update Course explores recent trends and evidence-based outcomes involving pharmacotherapeutic choices and diagnostic decision-making in NP practice.  Using a systematic approach, emerging trends of the latest pharmacotherapeutic agents, as well as controversies in infectious disease management will be presented.  Recently approved antimicrobials, drug resistance, rational use of both inpatient and outpatient antibiotics, as well as the latest drug warnings will be explored.  Additionally, treatment updates for a variety of infections and disorders including pneumonia, MRSA, viral dilemmas, STDs/STIs, immunizations and vaccinations will be covered, incorporating case study trivial analyses throughout the course.

Faculty:

Thomas W. Barkley, Jr., DSN, ACNP-BC is a Professor of Nursing and Director of Graduate and Nurse Practitioner Programs at California State University, Los Angeles.  Dr. Barkley has over 12 years experience actively teaching in the certification review continuing education business.  Since October, 2002, he has owned Barkley & Associates, a nation wide nurse practitioner certification review/clinical update continuing education company.

Upon completion of this course, the participant should be able to:

• Identify recent developments, trends and various pharmacologic controversies in the management of select infectious diseases and disorders

• Recognize current evidence-based outcomes impacting pharmacotherapeutic decisions in NP practice

• State new and evolving pharmacologic management options for select conditions

• Discuss newer antimicrobial agents, vaccines and tests, including appropriate use for prevention and treatment of bacterial, viral and fungal infections

• Describe the latest drug warnings and the potential impact to clinical practice

Day 1

1:00 p.m.         Welcome Pharmacology Update:  Emerging Trends

·                    The Latest Newly-Approved Pharmacotherapeutic Agents

·                    Drug Warnings:  What to Watch and Why

·                    Trivial Analyses

4:00 p.m.         Pharmacology Update:  Infectious Diseases

·                    Recently Approved Antimicrobials

·                    Inpatient Antibiotic Controversies

·                    Rational Use of Outpatient Antibiotics:  What’s New?

·                    Drug Resistance Update

·                    Newer Tests and Diagnostics

·                    Immunizations and Vaccinations

·                    Trivial Analyses

6:00 p.m.         Adjourn

Day 2

7:15 a.m.         Continental Breakfast

7:30 a.m.         Sex, Herpes and HIV Update:  What’s Going On 

ü                  Pharmacology Update:  STDs/STIs

ü                  Herpes:  Which One?  What’s New?

ü                  HIV Update for the Non-expert Practitioner

ü                  Trivial Analyses

10:00 a.m.       Infectious Diseases Update:  Controversies in Disease  Management

ü                  Pharmacotherapeutic Management Update for

ü                  Select Infectious Diseases and Disorders

ü                  Upper Respiratory Tract Infections:  Nose to Lungs

ü                  Influenza:  A, B or What’s Next?

ü                  Endocarditis:  Did You Miss Diagnose?

ü                  Nosocomial Infections:  A Staggering Look

ü                  Bone/Joint Infections:  How Deep to Cover?

ü                  Cellulitis, Abscess or Both?

ü                  Methicillin-resistant S. aureus (MRSA) and Community-acquired Methicillin   Resistant S. aureus (CA-MRSA):  Different Problems?

ü                  Community-acquired Pneumonia (CAP):  The Latest

ü                  Viral Dilemmas:  Order Something?

ü                  Others

ü                  Trivial Analyses

12:30 p.m.       Adjourn/Evaluations/Continuing Education Unit Certificates